Clinical Trials Recruiting near Birmingham, AL
827 clinical trials have a recruiting site within 25 miles of Birmingham, Alabama, according to ClinicalTrials.gov data processed . The closest recruiting site is within 1 mile of the city center.
Distances are measured from the city center to each site's city, so they are approximate.
Recruiting now
Studies enrolling near Birmingham
- A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
NCT07144280
- Phase 3
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 10 sites within 25 mi
- MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
NCT03072927
- Observational
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 8 sites within 25 mi
- A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
NCT05208762
- Phase 1
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 25 mi
- A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
NCT06866405
- Phase 3
- Ages 0 years and older
- Sex: All
- Accepts healthy volunteers
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 25 mi
- BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
NCT07160244
- Phase 3
- Ages 1 day to 49 years
- Sex: All
- Accepts healthy volunteers
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 25 mi
- A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
NCT07206225
- Phase 1
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 25 mi
- A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
NCT06873945
- Phase 3
- Ages 12 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 25 mi
- RAD 1802: Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI)
NCT03643861
- Interventional
- Ages 18 to 99 years
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
NCT04088071
- Observational
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
NCT04093388
- Interventional
- Ages 21 to 65 years
- Sex: Female
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
NCT04262206
- Phase 4
- Ages 75 years and older
- Sex: All
- Accepts healthy volunteers
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
NCT04378790
- Phase 3
- Ages 3 to 13 years
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
NCT05338697
- Observational
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
NCT05624996
- Phase 3
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
NCT05712200
- Phase 3
- Ages 65 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
NCT05946213
- Phase 3
- Ages 18 years and older
- Sex: Male
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole
NCT06261840
- Phase 4
- Ages 18 years and older
- Sex: All
- Accepts healthy volunteers
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374
- Phase 3
- Ages 18 to 75 years
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
NCT06513962
- Phase 3
- Ages Up to 39 years
- Sex: Female
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
NCT06562543
- Phase 4
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
NCT06677060
- Phase 3
- Ages 40 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
NCT06947993
- Phase 2
- Ages 18 to 100 years
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
NCT06989437
- Phase 2/3
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
NCT07000357
- Phase 3
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
NCT07136012
- Phase 3
- Ages 50 to 105 years
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
NCT07143669
- Observational
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
NCT07181109
- Phase 3
- Ages 18 years and older
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
NCT07231419
- Phase 3
- Ages 18 to 80 years
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
- A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
NCT07340320
- Phase 2
- Ages 18 to 75 years
- Sex: All
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 25 mi
By condition
Clinical trials in Birmingham by condition
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.